These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 9657137

  • 1. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
    André P, Brouland JP, Roussi J, Bonneau M, Pignaud G, Bal dit Sollier C, Hainaud P, Vaiman M, Drouet L.
    Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An experimental model for testing von Willebrand factor function: successful SLA-matched crossed bone marrow transplantations between normal and von Willebrand pigs.
    Roussi J, Samama M, Vaiman M, Nichols T, Pignaud G, Bonneau M, Sigman J, de Castro H, Griggs T, Drouet L.
    Exp Hematol; 1996 Apr; 24(5):585-91. PubMed ID: 8605962
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF, Vandeputte N, Pareyn I, Petrus I, Lenting PJ, Chuah MK, VandenDriessche T, Deckmyn H, Vanhoorelbeke K.
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [Abstract] [Full Text] [Related]

  • 6. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.
    Nichols TC, Samama CM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2455-9. PubMed ID: 7708664
    [Abstract] [Full Text] [Related]

  • 7. Association between bleeding time and platelet adherence to artery subendothelium.
    Sakariassen KS, Bolhuis PA, Blombäck M, Thorell L, Blombäck B, Sixma JJ.
    Thromb Haemost; 1984 Oct 31; 52(2):144-7. PubMed ID: 6441301
    [Abstract] [Full Text] [Related]

  • 8. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J.
    Haematologica; 1998 Nov 31; 83(11):1009-14. PubMed ID: 9864923
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U, Metzner HJ, Müller HG.
    Semin Thromb Hemost; 2006 Sep 31; 32(6):626-35. PubMed ID: 16977573
    [Abstract] [Full Text] [Related]

  • 11. The factor VIII/von Willebrand factor complex: basic and clinical issues.
    Federici AB.
    Haematologica; 2003 Jun 31; 88(6):EREP02. PubMed ID: 12826528
    [Abstract] [Full Text] [Related]

  • 12. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J, Escolar G, Casamiquela R, Bravo MI, Jorquera JI, Castillo R, Ordinas A, Vicente V.
    Haematologica; 1999 Jan 31; 84(1):5-11. PubMed ID: 10091386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 31; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 15. Interaction of the von Willebrand factor with platelets and thrombosis.
    Perutelli P, Mori PG.
    Recenti Prog Med; 1997 Nov 31; 88(11):526-9. PubMed ID: 9401429
    [Abstract] [Full Text] [Related]

  • 16. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I, Morris D, Konkle BA.
    Haemophilia; 2009 Jan 31; 15(1):131-4. PubMed ID: 18976254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA.
    Blood Coagul Fibrinolysis; 2009 Mar 31; 20(2):89-100. PubMed ID: 19786936
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.